NICOTINAMIDE ADENINE DINUCLEOTIDE 1G & TIRZEPATIDE'S SUCCESSOR : A UNITED KINGDOM UPDATE

The growing interest in NAD+ supplementation, particularly at a high dosage of 1g , continues to build within the British medical community. Concurrently, attention is focused on Retatrutide, a groundbreaking GLP-1 medication being viewed by many as a potential replacement to Tirzepatide. At pres